Head circumference in the clinical detection of PTEN hamartoma tumor syndrome in a clinic population at high-risk of breast cancer
- 27 March 2010
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 124 (2) , 459-465
Abstract
PTEN Hamartoma Tumor Syndrome (PHTS) is often recognized by the presence of macrocephaly and associated mucocutaneous features, and is notable for a profound predisposition to breast and thyroid cancers. Head circumference (HC) is rarely measured when evaluating women at high risk for breast cancer, but may offer insight into characterizing cancer risk. Patients enrolled in the University of Michigan Cancer Genetics registry for breast cancer evaluation were analyzed for personal and family history of cancer and features of PHTS. This group of women was compared to all women who had undergone PTEN testing and whether or not they met clinical criteria for PHTS. Among the 164 women referred for breast cancer risk evaluation, a statistically significant difference in mean HC was found between women who did (57.3 cm) and did not (55.4 cm) meet clinical criteria for PHTS with both values below the established threshold for macrocephaly (58 cm). The sensitivity and specificity of macrocephaly for the presence of a PTEN mutation were 100 and 53%, respectively, among the 28 women tested. The positive predictive value was 14%. PTEN mutation positive and PTEN mutation negative women were not well differentiated by PHTS clinical criteria (P = 0.2348). The high sensitivity of HC suggests that this simple measure can improve the detection of unrecognized patients with PHTS. Measuring HC is a useful clinical feature, but is insufficient as a singular screening tool for PHTS. Even in a high risk population, the PPV of this test is low. Diagnosis of this important genetic syndrome still relies heavily on detailed history and full physical exam.Keywords
This publication has 10 references indexed in Scilit:
- Hereditary Breast Cancer: Part I. Diagnosing Hereditary Breast Cancer SyndromesThe Breast Journal, 2007
- Molecular Classification of Patients With Unexplained Hamartomatous and Hyperplastic PolyposisJAMA, 2005
- Evaluation of breast involvement in relation to Cowden syndrome: a radiological and clinicopathological study of patients with PTEN germ-line mutationsEuropean Radiology, 2005
- Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome: Table 1Journal of Medical Genetics, 2004
- Recognition and Management of Hereditary Breast Cancer SyndromesThe Oncologist, 2004
- Will the real Cowden syndrome please stand up: revised diagnostic criteriaJournal of Medical Genetics, 2000
- Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutationHuman Molecular Genetics, 1998
- Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndromeNature Genetics, 1997
- Head Circumference Reference Data: Birth to 18 YearsPediatrics, 1987
- HEAD CIRCUMFERENCE FROM BIRTH TO EIGHTEEN YEARSPediatrics, 1968